Diagnosis value of 18F-Fluoro-d-glucose positron emission tomography-computed tomography in pulmonary hamartoma: a retrospective study and systematic review

Diagnosis value of 18F-Fluoro-d-glucose positron emission tomography-computed tomography in pulmonary hamartoma: a retrospective study and systematic review

Abstract Purpose The diagnosis of pulmonary hamartoma (PH) based on computed tomography (CT) is a challenge, especially in patients with atypical imaging characteristics. This study was aimed at summarizing the imaging characteristic of 18F-Fluoro-d-glucose positron emission tomography-computed tomo...

Full description

Bibliographic Details
Main Authors:	Sheng Ye, Shen Meng, Shuang Bian, Cuicui Zhao, Jin Yang, Wei Lei
Format:	Article
Language:	English
Published:	BMC 2023-02-01
Series:	BMC Medical Imaging
Subjects:	PET-CT CT Diagnosis Pulmonary hamartoma SUVmax
Online Access:	https://doi.org/10.1186/s12880-023-00981-z

Similar Items

Clinical Impact of Dual Time Point <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging in Pancreatic Cancer
by: Takahiro Einama, et al.
Published: (2022-07-01)

Ground glass pulmonary nodules: their significance in oncology patients and the role of computer tomography and 18F–fluorodeoxyglucose positron emission tomography
by: Laura Evangelista, et al.
Published: (2018-02-01)

Use of 18F‐2‐deoxy‐2‐fluoro‐D‐glucose positron emission tomography/computed tomography for staging thyroid carcinoma in a cat
by: Seonggweon Kang, et al.
Published: (2023-05-01)

18F-Fluorodeoxyglucose Positron Emission Tomography Is Useful in the Evaluation of Prognosis in Retroperitoneal Sarcoma
by: Toru Wakamatsu, et al.
Published: (2021-09-01)

Effect of Whole-body [18F]Fluoro-2-deoxy-2-d-glucose Positron Emission Tomography in Patients with Suspected Brain Metastasis
by: Manish Ora, et al.
Published: (2023-08-01)

Is It Possible to Establish a Reliable Correlation between Maximum Standardized Uptake Value of 18-Fluorine Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and Histological Types of Non-Small Cell Lung Cancer? Analysis of the Italian VATS Group Database
by: Duilio Divisi, et al.
Published: (2021-10-01)

Primary pleural diffuse large B-cell Non Hodking's lymphoma on [18F]-2-fluoro-deoxy-D-glucose positron emission tomography/computed tomography
by: İlknur Ak Sivrikoz, et al.
Published: (2012-03-01)

Giant Polyostotic Fibrous Dysplasia: F-18-flourodeoxyglucose Positron Emission Tomography/Computerized Tomography and Radiologic Findings
by: Melis Baykara Ulusan, et al.
Published: (2020-03-01)

Prediction of 2-[<sup>18</sup>F]FDG PET-CT SUVmax for Adrenal Mass Characterization: A CT Radiomics Feasibility Study
by: Arnaldo Stanzione, et al.
Published: (2023-06-01)

Value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in assessment of response to preoperative chemotherapy in pediatric sarcoma
by: Ahmed Mohamed Rashad, et al.
Published: (2019-09-01)

Construction and validation of an 18F-FDG-PET/CT-based prognostic model to predict progression-free survival in newly diagnosed multiple myeloma patients
by: Xiaoqing Dong, et al.
Published: (2024-12-01)

An evaluation of the physiological uptake range of 18F-fluoro-2-deoxy-D-glucose in normal ovaries of seven dogs using positron emission tomography/computed tomography
by: Jinyoung Choi, et al.
Published: (2024-02-01)

Effect of steroid treatment on the diagnostic yield of baseline 18f-fluorodeoxyglucose positron emission tomography in aggressive B cell lymphoma
by: Karyn Revital Geiger, et al.
Published: (2022-09-01)

Prognostic value of pre-treatment FDG PET/CT SUVmax for metastatic lesions in de novo metastatic nasopharyngeal carcinoma following chemotherapy and locoregional radiotherapy
by: Wenbin Yan, et al.
Published: (2023-02-01)

The Role of Positron Emission Tomography- Computed Tomography/Magnetic Resonance Imaging in Modern Medicine
by: Sina Houshmand, et al.
Published: (2014-09-01)

A case report of calcific aterosclerosis demonstrated on 18-F-fluorodeoxyglucose positron emission tomography/computed tomography
by: Antonella Laria, et al.
Published: (2021-10-01)

Imaging characteristics of tenosynovial giant cell tumors on 18F-fluorodeoxyglucose positron emission tomography/computed tomography: a retrospective observational study
by: Kohei Mizuta, et al.
Published: (2023-07-01)

Baseline SUV Range for Liver and Blood Pool in Patients Undergoing F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography
by: Yasemin Parlak, et al.
Published: (2019-09-01)

Positron Emission Tomography in Breast Cancer
by: Jose Luis Vercher-Conejero, et al.
Published: (2015-03-01)

Multiple myeloma: characterization of patients through the analysis of semiquantitative parameters with 18F-FDG PET
by: Maria Silvia De Feo, et al.
Published: (2023-06-01)

Differentiation of Hamartomas and Malignant Lung Tumors in Single-Phased Dual-Energy Computed Tomography
by: Moritz T. Winkelmann, et al.
Published: (2024-02-01)

Glucose Metabolism Quantified by SUVmax on Baseline FDG-PET/CT Predicts Survival in Newly Diagnosed Multiple Myeloma Patients: Combined Harmonized Analysis of Two Prospective Phase III Trials
by: Anne-Victoire Michaud-Robert, et al.
Published: (2020-09-01)

18F-fluorodeoxyglucose–positron emission tomography/computed tomography for the diagnosis of polymyalgia-like illnesses: a retrospective study
by: Hideyuki Horikoshi, et al.
Published: (2020-04-01)

The role of (18F)-fluoro-D-glucose positron emission tomography/computed tomography in the surveillance of abnormal myocardial energy metabolism and cardiac dysfunction in a rat model of cardiopulmonary resuscitation
by: Liming Pan, et al.
Published: (2023-05-01)

18F‐fluorodeoxyglucose‐positron emission tomography/computed tomography delineates involved sites in the cervical spine in Langerhans cell histiocytosis
by: Shinsaku Imashuku, et al.
Published: (2022-08-01)

Usefulness of 18F‐fluorodeoxyglucose positron emission tomography/computed tomography for predicting the prognosis and treatment response of neoadjuvant therapy for pancreatic ductal adenocarcinoma
by: Takahiro Yokose, et al.
Published: (2020-06-01)

Significance of metabolic parameters and biochemical indexes of 18F-FDG PET/CT in the mid-term evaluation and prognosis of diffuse large B-cell lymphoma
by: Zhang Fan, Zhang Guoxu, Liu Xiuting, Wang Jigang, Liu Yanqin, Tong Danjiang, Liu Jinghua, Zhou Fan
Published: (2022-03-01)

Harmonization of standard uptake values across different positron emission tomography/computed tomography systems and different reconstruction algorithms: validation in oncology patients
by: Yufei Song, et al.
Published: (2023-03-01)

Diagnostic accuracy of fluorine-18 fluorodeoxyglucose positron emission tomography for suspected primary and postoperative pyogenic spondylitis
by: Qingyu Zhang, et al.
Published: (2023-01-01)

Detection of Recurrent Cervical Cancer and Prediction of Its Patient Survival with Serum Squamous-Cell Carcinoma-Antigen and 2-[<sup>18</sup>F] Fluoro-2-Deoxy-d-Glucose-Positron Emission Tomography/Computed Tomography
by: Nan-Jing Peng, et al.
Published: (2020-08-01)

The Value of Semiquantitative Parameters Derived from <sup>18</sup>F-FDG PET/CT for Predicting Response to Neoadjuvant Chemotherapy in a Cohort of Patients with Different Molecular Subtypes of Breast Cancer
by: Luca Urso, et al.
Published: (2022-11-01)

Intelligent Labeling of Tumor Lesions Based on Positron Emission Tomography/Computed Tomography
by: Shiping Ye, et al.
Published: (2022-07-01)

Prospective Assessment of Fluorine-18-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography (FDG-PET/CT) for Early Identification of Checkpoint-Inhibitor-Induced Pseudoprogression
by: Sif Homburg, et al.
Published: (2024-02-01)

Integrating [<sup>18</sup>F]-Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography with Radiation Therapy and Immunomodulation in Precision Therapy for Solid Tumors
by: Conor M. Prendergast, et al.
Published: (2023-10-01)

Evaluating the value of 18F-PSMA-1007 PET/CT in the detection and identification of prostate cancer using histopathology as the standard
by: Liang Luo, et al.
Published: (2023-11-01)

Role of 18F-choline and 18F-fluorodeoxyglucose positron emission tomography in combination with magnetic resonance imaging in brachytherapy planning for locally advanced cervical cancer: A pilot study
by: Fadoua Rais, et al.
Published: (2023-07-01)

Elastofibroma Dorsi: Positron Emission Tomography/Computed Tomography Perspective
by: Tamer Aksoy
Published: (2019-09-01)

Enhanced Computed Tomography and <sup>18</sup>F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Uncommon Histiocytic Sarcoma of Small Intestine Arising after Gastric Large B-Cell Lymphoma
by: Miju Cheon, et al.
Published: (2023-10-01)

Correlation between EGFR mutation status and F18‐fluorodeoxyglucose positron emission tomography‐computed tomography image features in lung adenocarcinoma
by: Lei Zhu, et al.
Published: (2019-04-01)

DARS2 overexpression is associated with PET/CT metabolic parameters and affects glycolytic activity in lung adenocarcinoma
by: Xu-Sheng Liu, et al.
Published: (2023-08-01)